-
EP2370454
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2370454
| EP2370454 - WDRPUH EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.10.2017 Database last updated on 15.06.2024 | |
| Former | Examination is in progress Status updated on 27.01.2017 | Most recent event Tooltip | 06.10.2017 | Application deemed to be withdrawn | published on 08.11.2017 [2017/45] | Applicant(s) | For all designated states Oncotherapy Science, Inc. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 / JP | [2011/40] | Inventor(s) | 01 /
TSUNODA, Takuya c/o ONCOTHERAPY SCIENCE INC. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 / JP | 02 /
OHSAWA, Ryuji c/o ONCOTHERAPY SCIENCE INC. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 / JP | 03 /
YOSHIMURA, Sachiko c/o ONCOTHERAPY SCIENCE INC. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 / JP | 04 /
WATANABE, Tomohisa c/o ONCOTHERAPY SCIENCE INC. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 / JP | [2011/40] | Representative(s) | Zacco GmbH Bayerstrasse 83 80335 München / DE | [N/P] |
| Former [2011/40] | Plougmann & Vingtoft A/S Sundkrogsgade 9 P.O. Box 831 2100 Copenhagen Ø / DK | Application number, filing date | 09830200.3 | 03.12.2009 | WO2009JP06573 | Priority number, date | US20080200962P | 05.12.2008 Original published format: US 200962 P | US20090209704P | 09.03.2009 Original published format: US 209704 P | [2011/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010064430 | Date: | 10.06.2010 | Language: | EN | [2010/23] | Type: | A1 Application with search report | No.: | EP2370454 | Date: | 05.10.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.06.2010 takes the place of the publication of the European patent application. | [2011/40] | Search report(s) | International search report - published on: | JP | 10.06.2010 | (Supplementary) European search report - dispatched on: | EP | 21.10.2013 | Classification | IPC: | C07K7/06, A61K39/00, A61P35/00, C12N5/0783, C12N5/0786, C12N15/09 | [2011/40] | CPC: |
A61K39/0011 (EP,KR,US);
C07K14/4748 (KR,US);
C07K7/06 (US);
A61K38/03 (KR);
A61K39/4611 (EP,KR);
A61K39/464402 (EP,KR);
A61P35/00 (EP);
A61P37/04 (EP);
C07K14/47 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Title | German: | WDRPUH-EPITOP-PEPTIDE UND DIESE ENTHALTENDE IMPFSTOFFE | [2011/40] | English: | WDRPUH EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME | [2011/40] | French: | PEPTIDES À ÉPITOPE WDRPUH ET VACCINS LES INCLUANT | [2011/40] | Entry into regional phase | 30.06.2011 | National basic fee paid | 30.06.2011 | Search fee paid | 30.06.2011 | Designation fee(s) paid | 30.06.2011 | Examination fee paid | Examination procedure | 30.06.2011 | Examination requested [2011/40] | 30.04.2014 | Amendment by applicant (claims and/or description) | 30.01.2017 | Despatch of a communication from the examining division (Time limit: M04) | 10.06.2017 | Application deemed to be withdrawn, date of legal effect [2017/45] | 04.07.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/45] | Divisional application(s) | EP17167553.1 / EP3219720 | EP22158260.4 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 30.01.2017 | Fees paid | Renewal fee | 23.12.2011 | Renewal fee patent year 03 | 19.12.2012 | Renewal fee patent year 04 | 27.12.2013 | Renewal fee patent year 05 | 22.12.2014 | Renewal fee patent year 06 | 22.12.2015 | Renewal fee patent year 07 | 23.12.2016 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] - P. G. COULIE ET AL, "From tumor antigens to immunotherapy", INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, (20010801), vol. 6, no. 4, doi:10.1007/PL00012101, ISSN 1341-9625, pages 163 - 170, XP055051786 [A] 1,7-11,17 * the whole document * DOI: http://dx.doi.org/10.1007/PL00012101 | [A] - STEFAN STEVANOVIC, "Identification of tumour-associated t-cell epitopes for vaccine development", NATURE REVIEWS CANCER, (20020701), vol. 2, no. 7, doi:10.1038/nrc841, ISSN 1474-1768, pages 514 - 514, XP055017371 [A] 1,7-11,17 * the whole document * DOI: http://dx.doi.org/10.1038/nrc841 | [A] - HARPREET SINGH-JASUJA ET AL, "The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy", CANCER IMMUNOLOGY, IMMUNOTHERAPY, (20040301), vol. 53, no. 3, doi:10.1007/s00262-003-0480-x, ISSN 0340-7004, pages 187 - 195, XP055015114 [A] 1,7-11,17 * the whole document * DOI: http://dx.doi.org/10.1007/s00262-003-0480-x | [A] - BROSSART P ET AL, "Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, (19990615), vol. 93, no. 12, ISSN 0006-4971, pages 4309 - 4317, XP002147432 [A] 1,7-11,17 * the whole document * | [A] - TANAKA YOSHIYUKI ET AL, "Mammaglobin-A is a tumor-associated antigen in human breast carcinoma.", SURGERY (ST LOUIS), (200301), vol. 133, no. 1, ISSN 0039-6060, pages 74 - 80, XP009172622 [A] 1,7-11,17 * the whole document * DOI: http://dx.doi.org/10.1067/msy.2003.92 | International search | [Y]WO03104276 (ONCOTHERAPY SCIENCE INC [JP], et al); | [Y]WO2004024766 (ONCOTHERAPY SCIENCE INC [JP], et al); | [Y]WO2008126413 (ONCOTHERAPY SCIENCE INC [JP], et al); | [Y] - SILVA F. P. ET AL., "WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation.", NEOPLASIA, (2005), vol. 7, no. 4, pages 348 - 355, XP009171691 DOI: http://dx.doi.org/10.1593/neo.04544 |